Syneos Health, LLC Sustainability Profile
Syneos Health, LLC, a leading biopharmaceutical solutions organisation headquartered in the United States, has been at the forefront of the healthcare industry since its founding in 2018. With a strong presence in North America, Europe, and Asia, Syneos Health offers a unique blend of clinical and commercial services designed to accelerate the delivery of innovative therapies to market. The company specialises in providing integrated solutions that encompass clinical development, commercialisation, and consulting services. Syneos Health distinguishes itself through its commitment to harnessing data and technology, enabling clients to navigate the complexities of drug development efficiently. Recognised for its strategic approach, the company has achieved significant milestones, positioning itself as a trusted partner for biopharmaceutical companies worldwide.
DitchCarbon Score
How does Syneos Health, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Syneos Health, LLC's score of 68 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Syneos Health, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Syneos Health, Inc., which may influence its climate commitments and initiatives. While there are no documented reduction targets or specific climate pledges from Syneos Health, LLC, it is important to note that any climate-related initiatives or targets would likely be inherited from its parent organisation, Syneos Health, Inc. This relationship suggests that Syneos Health, LLC may align with broader corporate sustainability goals set by Syneos Health, Inc., although specific details are not available. As a participant in the industry, Syneos Health, LLC is expected to engage in climate action and sustainability efforts, potentially following frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), as indicated by the cascading data from Syneos Health, Inc. However, without specific emissions data or reduction targets, the company's current climate impact remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 16,298,000 | 00,000,000 |
| Scope 2 | 9,704,000 | 0,000,000 |
| Scope 3 | 261,804,000 | 000,000,000 |
How Carbon Intensive is Syneos Health, LLC's Industry?
How Carbon Intensive is Syneos Health, LLC's Location?
Syneos Health, LLC's Scope 3 Categories Breakdown
Syneos Health, LLC's Scope 3 emissions, which decreased by 14% last year and decreased by approximately 14% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 77% of Scope 3 emissions.
Top Scope 3 Categories
Syneos Health, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Syneos Health, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
